Safety and Tolerability of Secukinumab in Patients with Active Ankylosing Spondylitis: Pooled Safety Analysis of Two Phase 3, Randomized, Controlled Trials

被引：0
|
作者：
Deodhar, Atul A. [1 ]
Baeten, Dominique [2 ]
Sieper, Joachim [3 ]
Porter, Brian [4 ]
Widmer, Albert [5 ]
Richards, Hanno [5 ]
机构：
[1] Oregon Hlth & Sci Univ, Div Arthrit & Rheumat Dis, Portland, OR 97201 USA
[2] Univ Amsterdam, Acad Med Ctr, Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Clin Benjamin Franklin, Berlin, Germany
[4] Novartis Pharmaceut, E Hanover, NJ USA
[5] Novartis Pharma AG, Basel, Switzerland
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
SIGNIFICANTLY IMPROVES SIGNS; PLACEBO-CONTROLLED TRIAL; MONOCLONAL-ANTIBODY; INTERLEUKIN-17A; SYMPTOMS; PHASE-3;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2887
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Safety and tolerability of adjunctive brivaracetam in children with focal seizures: Interim analysis of pooled data from two open-label trials
    Patel, Anup D.
    Badalamenti, Vincent
    Gasalla, Teresa
    Elmoufti, Sami
    Elshoff, Jan-Peer
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2020, 25 : 68 - 76
  • [32] Effectiveness, Safety, and Predictors of Good Clinical Response in 1250 Patients Treated with Adalimumab for Active Ankylosing Spondylitis
    Rudwaleit, Martin
    Claudepierre, Pascal
    Wordsworth, Paul
    Loza Cortina, Eduardo
    Sieper, Joachim
    Kron, Martina
    Carcereri-de-Prati, Roberto
    Kupper, Hartmut
    Kary, Sonja
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (04) : 801 - 808
  • [33] Efficacy and safety of sapropterin dihydrochloride in patients with phenylketonuria: A meta-analysis of randomized controlled trials
    Qu, Jinghan
    Yang, Ting
    Wang, Ente
    Li, Min
    Chen, Chaoyang
    Ma, Lingyun
    Zhou, Ying
    Cui, Yimin
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (05) : 893 - 899
  • [34] SECUKINUMAB EFFICACY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: POOLED ANALYSIS OF FOUR PHASE 3 TRIALS BY PRIOR ANTI-TNF THERAPY AND CONCOMITANT METHOTREXATE USE
    Kirkham, B.
    Mease, P. J.
    Nash, P.
    Balsa, A.
    Combe, B.
    Rech, J.
    Martin, R.
    Ligozio, G.
    Abrams, K.
    Pricop, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1597 - 1597
  • [35] Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials
    Adsit, Sandra
    Rivas Zaldivar, Enrique
    Sofen, Howard
    Dei-Cas, Ignacio
    Maldonado-Garcia, Cesar
    Penaranda, Elkin O.
    Puig, Luis
    Meng, Xiangyi
    Fox, Todd
    Guana, Adriana
    ADVANCES IN THERAPY, 2017, 34 (06) : 1327 - 1339
  • [36] Risk of infection in patients with spondyloarthritis and ankylosing spondylitis receiving antitumor necrosis factor therapy: A meta-analysis of randomized controlled trials
    Xu, Zhigao
    Xu, Peipei
    Fan, Wei
    Yang, Gui
    Wang, June
    Cheng, Qingyuan
    Yu, Mingxia
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (04) : 3491 - 3500
  • [37] Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data
    Deodhar, A.
    Mease, P. J.
    McInnes, I. B.
    Baraliakos, X.
    Reich, K.
    Blauvelt, A.
    Leonardi, C.
    Porter, B.
    Gupta, A. Das
    Widmer, A.
    Pricop, L.
    Fox, T.
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [38] Comparison of the efficacy and safety of tofacitinib and mavrilimumab in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials
    Sung, Yoon-Kyoung
    Lee, Young Ho
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (08) : 557 - 565
  • [39] Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies
    Coates, Laura C.
    Wallman, Johan K.
    McGonagle, Dennis
    Schett, Georg A.
    McInnes, Iain B.
    Mease, Philip J.
    Rasouliyan, Lawrence
    Quebe-Fehling, Erhard
    Asquith, Darren L.
    Fasth, Andreas E. R.
    Pricop, Luminita
    Gaillez, Corine
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (01)
  • [40] Bimekizumab safety in patients with moderate-to-severe plaque psoriasis: pooled data from up to 3 years of treatment in randomized phase III trials
    Gordon, Kenneth B.
    Langley, Richard G.
    Warren, Richard B.
    Okubo, Yukari
    Rosmarin, David
    Lebwohl, Mark
    Peterson, Luke
    Madden, Cynthia
    de Cuyper, Dirk
    Davies, Owen
    Thaci, Diamant
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 (04) : 477 - 485
12345